Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single rising intravenous doses of BI 765845 in healthy male Japanese subjects
jRCT2031230092Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in myocardial infarction (MI) comparing BI 765845 with Placebo (2 arms). Started Jul 2023; status: completed.
02
Drugs
BI 765845
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCT2031230092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230092.